Search Results - "Mayer, Stanislas"
-
1
817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundElevated levels of Prostaglandin E2 (PGE2), an eicosanoid notably synthesized by the cyclooxygenase-2 (COX-2), exert strong immunosuppressive effects…”
Get full text
Journal Article -
2
Pd-PEPPSI-IPent super(Cl): A Useful Catalyst for the Coupling of 2-Aminopyridine Derivatives
Published in Chemistry : a European journal (01-03-2017)“…The Pd-PEPPSI-IPent super(Cl) precatalyst (PEPPSI=pyridine-enhanced precatalyst preparation stabilisation initiation) has been demonstrated to be highly…”
Get full text
Journal Article -
3
A General Protocol for the Broad-Spectrum Cross-Coupling of Nonactivated Sterically Hindered 1° and 2° Amines
Published in Organometallics (25-09-2017)“…While notable advances have been reported for the metal-catalyzed cross-coupling of bulky amines, to date no set of reported conditions has proven general for…”
Get full text
Journal Article -
4
Pd‐PEPPSI‐IPentCl: A Useful Catalyst for the Coupling of 2‐Aminopyridine Derivatives
Published in Chemistry : a European journal (02-03-2017)“…The Pd‐PEPPSI‐IPentCl precatalyst (PEPPSI=pyridine‐enhanced precatalyst preparation stabilisation initiation) has been demonstrated to be highly effective in…”
Get full text
Journal Article -
5
Pd-PEPPSI-IPent Cl : A Useful Catalyst for the Coupling of 2-Aminopyridine Derivatives
Published in Chemistry : a European journal (02-03-2017)“…The Pd-PEPPSI-IPent precatalyst (PEPPSI=pyridine-enhanced precatalyst preparation stabilisation initiation) has been demonstrated to be highly effective in the…”
Get full text
Journal Article -
6
Abstract 6697: DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Elevated levels of Prostaglandin E2 (PGE2), an eicosanoid notably synthesized by the cyclooxygenase-2 (COX-2), exert strong immunosuppressive effects in the…”
Get full text
Journal Article -
7
Discovery, Structure–Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
Published in Journal of medicinal chemistry (26-10-2017)“…The metabotropic glutamate receptor 4 (mGluR4) is an emerging target for the treatment of Parkinson’s disease (PD). However, since the discovery of its…”
Get full text
Journal Article -
8
Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies
Published in Journal of medicinal chemistry (11-07-2024)“…Decreased activity and expression of the G-protein coupled receptor GPR88 is linked to many behavior-linked neurological disorders. Published preclinical GPR88…”
Get full text
Journal Article -
9
-
10
Regioselective Formylation of Ethyl 3,4-Dihydro-2H-1,4- benzoxazine-2-carboxylate or 2-Acetate Derivatives
Published in Heterocycles (01-10-2001)Get full text
Journal Article -
11
High-Throughput Screening of TRPV1 Ligands in the Light of the Bioluminescence Resonance Energy Transfer Technique
Published in Molecular pharmacology (01-09-2021)“…Ion channels are attractive drug targets for many therapeutic applications. However, high-throughput screening (HTS) of drug candidates is difficult and…”
Get full text
Journal Article -
12
Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present)
Published in Expert opinion on therapeutic patents (01-01-2015)“…This review focuses on the medicinal chemistry efforts directed toward the identification of competitive and noncompetitive antagonists of glutamate at group…”
Get more information
Journal Article -
13
Chemical Switch of a Metabotropic Glutamate Receptor 2 Silent Allosteric Modulator into Dual Metabotropic Glutamate Receptor 2/3 Negative/Positive Allosteric Modulators
Published in Journal of medicinal chemistry (23-12-2010)“…Using an mGluR2 FRET-based binding assay, binders of the transmembrane region devoid of functional activity were identified. It is reported that slight…”
Get full text
Journal Article -
14
HGG-23. GLUTAMINOLYSIS INVOLVEMENT AND ITS TARGETING IN PEDIATRIC HIGH GRADE GLIOMAS: A NEW WAY OF TREATMENT
Published in Neuro-oncology (Charlottesville, Va.) (23-04-2019)“…Abstract Gliomas are the most common type of pediatric brain tumors. One third of them are high grade gliomas (pHGG) with a significant dismal prognosis and a…”
Get full text
Journal Article -
15
Abstract 684: DT-9045, a novel PAR2 inhibitor with best-in-class properties that reduces resistance to both EGFR-targeting therapies and immunotherapy in oncology models
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Protease-activated receptor 2 (PAR2) is a promising therapeutic target in oncology and immuno-oncology. It is upregulated and associated with poor prognosis in…”
Get full text
Journal Article -
16
Abstract 4961: Novel biased PAR2 inhibitors with best-in-class properties reduce resistance to both chemotherapy and immunotherapy in oncology models
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…A large-scale meta-analysis has recently identified Protease-activated receptor 2 (PAR2) gene expression to be significantly associated with resistance to…”
Get full text
Journal Article -
17
Synthesis of 4-(5-Iodo-3-Methylpyrazolyl) Phenylsulfonamide and Its Elaboration To a COX II Inhibitor Library by Solution-Phase Suzuki Coupling Using Pd/C as a Solid-Supported Catalyst
Published in Journal of combinatorial chemistry (01-03-2003)“…An effective synthesis of 4-(5-iodo-3-methylpyrazolyl) phenylsulfonamide has been developed. This aromatic iodide template served as an efficient oxidative…”
Get full text
Journal Article -
18
Screening of Inhibitors Using Enzymes Entrapped in Sol−Gel-Derived Materials
Published in Analytical chemistry (Washington) (15-05-2003)“…In recent years, a number of new methods have been reported that make use of immobilized enzymes either on microarrays or in bioaffinity columns for…”
Get full text
Journal Article -
19
A 2.13 Å Structure of E. coli Dihydrofolate Reductase Bound to a Novel Competitive Inhibitor Reveals a New Binding Surface Involving the M20 Loop Region
Published in Journal of medicinal chemistry (30-11-2006)“…Dihydrofolate reductase (DHFR) is a vital metabolic enzyme and thus a clinically prominent target in the design of antimetabolites. In this work, we identify…”
Get full text
Journal Article -
20
Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): Identification of a new group III metabotropic glutamate receptor selective agonist
Published in Bioorganic & medicinal chemistry letters (15-09-2006)“…A new family of mGlu receptor orthosteric ligands called APTCs was designed and synthesized using parallel chemistry. Amongst them, 8a06 (FP0429) has been…”
Get full text
Journal Article